Mechanism of action of primary cell derived biologic

Details for Australian Patent Application No. 2009251277 (hide)

Owner IRx Therapeutics, Inc.

Inventors Hadden, John W.

Agent Lord and Company

Pub. Number AU-A-2009251277

PCT Pub. Number WO2009/146392

Priority 61/056,925 29.05.08 US

Filing date 29 May 2009

Wipo publication date 3 December 2009

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/146392 Priority application(s): WO2009/146392

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009251288-Methods and devices for treating neuropathy and loss of protective sensation

2009251276-Close proximity communication device and methods